Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5245]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Mechanisms of resistance to CDK4/6 inhibitors in triple negative breast cancer
Dr Uzma Asghar - The Institute of Cancer Research, London, UK
Mechanisms of resistance to CDK4/6 inhibitors in triple negative breast cancer ( Dr Uzma Asghar - The Institute of Cancer Research, London, UK )
12 May 2017
pSTAT3 in luminal breast cancer - results from BIG-2-98 trial
Dr Amir Sonnenblick - Hebrew University Medical Center, Jerusalem, Israel
pSTAT3 in luminal breast cancer - results from BIG-2-98 trial ( Dr Amir Sonnenblick - Hebrew University Medical Center, Jerusalem, Israel )
12 May 2017
Adaptive trial design on breast cancer
Prof Laura Vant Veer - University of California San Francisco, San Francisco...
Adaptive trial design on breast cancer ( Prof Laura Vant Veer - University of California San Francisco, San Francisco, USA )
11 May 2017
The molecular characterisation of oesophageal adenocarcinoma
Prof Rebecca Fitzgerald - University of Cambridge, Cambridge, UK
The molecular characterisation of oesophageal adenocarcinoma ( Prof Rebecca Fitzgerald - University of Cambridge, Cambridge, UK )
27 Apr 2017
Discovering genes in mammary cancer by insertional mutagenesis
Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands
Discovering genes in mammary cancer by insertional mutagenesis ( Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands )
27 Apr 2017
Hallmarks of cancer cell development
Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne...
Hallmarks of cancer cell development ( Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland )
27 Apr 2017
Pembrolizumab and indoximod for melanoma
Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of...
Pembrolizumab and indoximod for melanoma ( Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA )
13 Apr 2017
Nivolumab for NSCLC: five years on
Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Nivolumab for NSCLC: five years on ( Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
12 Apr 2017
Long-term clinical outcomes and analyses of atezolizumab for mTNBC
Prof Peter Schmid - Barts Cancer Institute, London, UK
Long-term clinical outcomes and analyses of atezolizumab for mTNBC ( Prof Peter Schmid - Barts Cancer Institute, London, UK )
12 Apr 2017
Final overall survival analysis of MONARCH 1
Dr Hope Rugo - UCSF Medical Center, San Francisco, USA
Final overall survival analysis of MONARCH 1 ( Dr Hope Rugo - UCSF Medical Center, San Francisco, USA )
11 Apr 2017
Redefining tamoxifen for breast cancer
Gokul Das - Roswell Park Cancer Institute, Buffalo, USA
Redefining tamoxifen for breast cancer ( Gokul Das - Roswell Park Cancer Institute, Buffalo, USA )
11 Apr 2017
Final results of the HERACLES trial in HER2-amplified colorectal cancer
Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy
Final results of the HERACLES trial in HER2-amplified colorectal cancer ( Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy )
10 Apr 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation